A

Atlas Bio

HealthDrug DevelopmentB2B📍 Switzerland

Atlas Bio is a Swiss startup focused on improving drug development by tackling the high failure rate and aiming to move beyond animal testing. This funding round will support their efforts to create more effective and ethical pharmaceutical research processes.

Total raised
Undisclosed
tracked to date
Latest round
$12.5M
Oct 27, 2026

Is this your company?

Claim this profile to get matched with investors who fund Health startups in Switzerland.

Claim this profile →

🏆 Featured in Datapile’s Q4 2026 Switzerland Funding Report

Read the Q4 2026 Switzerland report →
Add this badge to your site
<a href="https://datapile.co/reports/q4-2026-switzerland-startup-funding" target="_blank" rel="noopener" style="display:inline-flex;align-items:center;gap:8px;padding:9px 16px;border-radius:9999px;background:#0B1224;color:#ffffff;font:600 13px/1.2 -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,Arial,sans-serif;text-decoration:none;border:1px solid #7C5CFF"><span style="display:inline-block;width:11px;height:11px;border-radius:3px;background:#7C5CFF"></span>Featured in Datapile&rsquo;s Q4 2026 Switzerland Funding Report</a>

Funding history

  1. 1
    $12.5MOct 27, 2026
    Announcement ↗

Atlas Bio in the news

Coverage of this company's funding, tracked by Datapile.

More Health companies

Recently funded startups in the same category.

Related on Datapile